Rheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study

scientific article published on 9 October 2017

Rheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1038/S41598-017-13168-8
P2888exact matchhttps://scigraph.springernature.com/pub.10.1038/s41598-017-13168-8
P932PMC publication ID5634412
P698PubMed publication ID28993680

P50authorPetroula ProitsiQ47504060
P2093author name stringAminah Noor Ahmad
John Francis Powell
Stefania Policicchio
P2860cites workPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementQ21562278
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseQ22251067
Depression and the risk of Alzheimer disease.Q50778247
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada.Q52019123
Alzheimer's disease: a study of epidemiological aspects.Q52092341
Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.Q52884779
Anti-inflammatory drugs and Alzheimer disease.Q53183421
Rheumatoid arthritis and senile dementia of the Alzheimer's type.Q53190347
Alzheimer's disease and rheumatoid arthritis.Q53316929
Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.Q53354093
Midlife Rheumatoid Arthritis Increases the Risk of Cognitive Impairment Two Decades Later: A Population-Based StudyQ59542847
The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in CanadaQ72829553
Population-based cohort studiesQ77376721
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsQ26866006
The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysisQ27022403
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteinsQ28168105
Genetics of rheumatoid arthritis contributes to biology and drug discoveryQ29417000
The pathogenesis of rheumatoid arthritisQ29614957
Type 2 diabetes as an inflammatory diseaseQ29617184
A claims data-based comparison of comorbidity in individuals with and without dementiaQ30570359
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetesQ33859600
2012 Alzheimer's disease facts and figuresQ34260109
Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer DiseaseQ34471227
Donepezil and memantine for moderate-to-severe Alzheimer's disease.Q34636487
Co-morbidity in rheumatoid arthritisQ35198206
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialQ35671005
The role of inflammation in Alzheimer's diseaseQ35913633
What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?Q36119363
Rheumatoid arthritis and cardiovascular diseaseQ37140079
Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).Q37297193
Selecting instruments for Mendelian randomization in the wake of genome-wide association studiesQ37401173
Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory diseaseQ37859679
Review: systemic inflammation and Alzheimer's diseaseQ38050498
Evolution of treatment for rheumatoid arthritisQ38065767
Immune attack: the role of inflammation in Alzheimer disease.Q38492631
Rheumatoid arthritis and the risk of dementia: A systematic review and meta-analysis.Q38692843
Beyond Mendelian randomization: how to interpret evidence of shared genetic predictorsQ40623861
Patterns of anti-inflammatory drug use and risk of dementia: a matched case-control studyQ40734133
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorQ40773355
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionQ40862437
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studiesQ41075378
A case-control study of Alzheimer's disease in ChinaQ41128795
A case-control study of Alzheimer's disease in AustraliaQ41198222
A case-control study of Alzheimer's diseaseQ41220542
Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid ArthritisQ41482717
A case-control study of dementia of the Alzheimer typeQ41500631
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA StatementQ42035537
Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's diseaseQ42452339
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort studyQ45792532
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.Q46003173
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis.Q48369444
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
rheumatoid arthritisQ187255
P304page(s)12861
P577publication date2017-10-09
P1433published inScientific ReportsQ2261792
P1476titleRheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study
P478volume7

Reverse relations

cites work (P2860)
Q58746581Alzheimer's Disease and Rheumatoid Arthritis: A Mendelian Randomization Study
Q89425020Causal association between rheumatoid arthritis and a decreased risk of Alzheimer's disease : A Mendelian randomization study
Q57816569Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease
Q92193179Nature's Derivative(s) as Alternative Anti-Alzheimer's Disease Treatments
Q90117853Rheumatoid arthritis and neurodegenerative dementia: a nested case-control study and a follow-up study using a national sample cohort
Q99585428Using Mendelian randomization to understand and develop treatments for neurodegenerative disease

Search more.